Apocrine Metaplasia - Causes, Symptoms, and Treatment

Introduction:

Apocrine metaplasia is a non-cancerous and morphological transformation noted in the glandular epithelial cells. It is usually present in the breasts. However, other anatomical sites, such as the skin, eyelids, and anogenital glands, are also affected. The term apocrine refers to the glands' thick and lipid-rich fluid secretion. The exact etiology of apocrine metaplasia has yet to be completely understood. However, the condition is caused due to hormonal changes and environmental stimuli. The major concern associated with apocrine metaplasia is malignancy (cancer). The condition is characterized by palpable masses in the breasts. There is a need for accurate diagnosis and proper treatment to prevent more concerning lesions. The article discusses apocrine metaplasia, its causes, signs and symptoms, diagnosis, treatment, and prevention. Understanding the underlying mechanism of apocrine metaplasia is crucial for guiding appropriate management strategies.

What Is Apocrine Metaplasia?

Apocrine metaplasia is a non-cancerous breast condition in which the epithelial cells are transformed into apocrine cells (cells present in the breasts). Apocrine cells produce a thick and lipid-rich fluid compared to the watery fluid of eccrine glands. The changes include an enlargement of the cytoplasm, the formation of luminal secretions, and the presence of eosinophilic granules. The condition is more commonly encountered in women over 50.

What Are the Causes of Apocrine Metaplasia?

Apocrine metaplasia is caused due to hormonal changes, genetic factors, and environmental stimuli. Several factors that lead to the development of the condition are as follows:

• Hormonal Changes: Hormones, such as estrogen and progesterone, play a role in the normal development of the breasts. Estrogen helps in the growth and development of breast epithelial cells and changes in cellular morphology. Progesterone enhances the lobular structures. During the menstrual cycle, the estrogen and progesterone hormones cause complex changes in the breast architecture. The estrogen and progesterone hormone fluctuations may cause changes in mammary epithelial cells and contribute to the development of apocrine metaplasia. The epithelial cells regulate mammary gland development and function.

• Genetic Factors: Certain genetic mutations can lead to the development of non-cancerous lesions. Gene mutations encoding estrogen and progesterone receptors may disrupt normal hormone regulation.

• Environmental Stimuli: Certain environmental factors, such as exposure to radiation or toxins, may lead to the development of apocrine metaplasia. In addition, ionizing radiation exposure is linked to an increased risk of non-cancerous or benign breast conditions.

• Reproductive Factors: Factors such as hormonal contraceptive use and first pregnancy age may increase the risk of apocrine metaplasia. The hormonal changes during pregnancy, lactation, and menopause can affect the differentiation of epithelial breast cells. Pregnancy at a late age is also associated with an increased risk of apocrine metaplasia.

What Are the Risk Factors for Apocrine Metaplasia?

The risk factors for apocrine metaplasia are as follows:

• Women are at higher risk than men.

• Excessive alcohol consumption.

• Being overweight.

• Women taking hormone replacement therapy medications.

• Lack of physical exercise.

• Lack of breastfeeding to a child.

• Women taking birth control pills.

What Are the Signs and Symptoms of Apocrine Metaplasia?

There are no typical signs and symptoms associated with apocrine metaplasia. These can be incidentally diagnosed through imaging studies and a biopsy. During routine breast examination, the noticeable signs and symptoms of apocrine metaplasia are as follows:

• Breast Mass: There can be palpable breast mass or lump.

• Pain or Discomfort: The person may experience pain or discomfort in the breast.

• Associated With Other Benign Breast Conditions: Apocrine metaplasia can be associated with other benign breast conditions, such as intraductal papillomas (non-cancerous tumors of the milk duct). The common symptoms include breast lumps, breast pain, and nipple discharge.

How Is Apocrine Metaplasia Diagnosed?

Diagnosis of apocrine metaplasia can be made by histopathological examination and biopsy. The common diagnostic procedures of apocrine metaplasia are as follows:

• Clinical Evaluation: The healthcare provider or pathologist may physically examine the breasts, take a thorough medical history, and assess signs and symptoms.

• Imaging Studies: Imaging studies are used to evaluate the breast lesions associated with apocrine metaplasia as follows:

  • Mammography: During mammography, low-dose X-rays are used to evaluate breast abnormalities and create detailed images of the breast tissue. These diagnose breast masses, calcifications, and distortions.

  • Breast Ultrasound: These use sound waves to form an image of breast tissue. The breast ultrasound differentiates solid and cystic masses.

  • Magnetic Resonance Imaging (MRI): During an MRI, the magnetic field and radio waves form a detailed image of the breast tissue. Breast MRI helps identify the extent of the disease. However, it does not provide a definite diagnosis of apocrine metaplasia.

• Biopsy: In case of a suspicious breast lesion, the biopsy is recommended for further evaluation. Several types of biopsy include fine needle aspiration biopsy, core needle biopsy of breast mass, or surgical biopsy. During a fine needle aspiration biopsy, the healthcare provider may take a breast tissue sample and send it to a pathology laboratory for histological examination to determine whether the tumor is cancerous or non-cancerous. In the case of core needle biopsy, the healthcare provider may use a wide needle to take a sample from the breast tissue. During a surgical biopsy, the healthcare provider may surgically remove a part of the tumor mass.

• Histological Examination: Histological features are essential for diagnosing apocrine metaplasia. Characteristic features include enlarged epithelial cells, abundant eosinophilic cytoplasm, and prominent granules. The enlarged epithelial cells may form solid aggregates within the breast tissue.

How Is Apocrine Metaplasia Treated?

There is no need for appropriate treatment for apocrine metaplasia. In cases where apocrine metaplasia is incidentally discovered, surveillance and follow-up are recommended to monitor the changes over time. If the condition is associated with other benign breast conditions, the treatment is indicated to relieve pain. The treatment measures include pain-relieving medications and hormonal therapy. The associated malignant breast conditions can be managed with surgery, chemotherapy, radiation therapy, and hormone therapy.

What Are the Complications Associated With Apocrine Metaplasia?

The complications associated with apocrine metaplasia are as follows:

• Apocrine metaplasia causes changes in breast density and makes it more difficult to detect abnormalities.

• Sometimes, the condition may resemble other malignant breast lesions, leading to misdiagnosis.

• It may cause psychological distress and anxiety in some individuals.

• Some studies suggest that apocrine metaplasia increases the risk of cancer in the future.

Conclusion:

In conclusion, apocrine metaplasia is a non-cancerous or benign condition that causes changes in the glandular breast tissue. Individuals may experience a lump or mass in the breast. Generally, the condition does not lead to any complications. However, it may pose challenges in diagnosing the condition. Regular breast examinations and consultation with the healthcare provider help manage any concerns with apocrine metaplasia.